Amicus Therapeutics Rare Disease Combo Therapy Wins Long-Awaited FDA Nod
An Amicus Therapeutics combination treatment for the rare enzyme deficiency Pompe disease now has FDA approval, giving the drugmaker the opportunity to help patients who don’t respond to Sanofi products…
Read More »